Vor Biopharma Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:VOR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -31.07 M-35.18 M-53.66 M-22.8 M-38.25 M -149.89 M Cash from investing activities -230 K646 K-244 K-48.97 M-263.24 M -311.81 M Cash from financing activities -606 K175.06 M21.55 M307.8 M74.87 M 579.28 M Free cash flow -31.07 M-35.18 M-53.66 M-22.8 M-38.25 M -149.89 M

News

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR)

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:VOR) 2026-01-16

Micron Tech and Citigroup among market cap stock movers on Wednesday

Vor Biopharma adds two investment partners to board of directors

Vor Biopharma (VOR): Initiating Hold Rating On Durable Telitacicept MG Study Data

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential

Vor Bio raises $150 million in private placement to fund clinical trials

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR)

JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential